11/11
How do patients with #ATTRCM die?
New insights from Kevin Alexander, MD and Masri Ahmad, MD #ATTRibuteCM at #HeartFailure2025
#CardioSky #MedSky #Cardiology
0
0
0
0
Hashtag
#HeartFailure2025
Advertisement · 728 × 90
10/11
Marianna Fontana presents new data at #HeartFailure2025 from #ATTRibuteCM
Exploring effects of acoramidis on functional capacity & QOL in patients with variant ATTR-CM.
6-minute walking distance - 87m (!) mean increase
KCCQ health status gain - 20pt (!) mean increase
#CardioSky #MedSky
0
0
1
0
8/11
New data from #ATTRibuteCM presented at #HeartFailure2025
Intriguing analysis by Kevin Alexander, MD. High-affinity TTR stabilizer acoramidis potentially associated with lower risks of AF/AFL events in #ATTRCM
#CardioSky #MedSky #Cardiology
0
0
1
0
7/11
Separately conducted supportive data for #CPETs as a potential novel endpoint in upcoming trials of cardiomyopathy at #HeartFailure2025
esc365.escardio.org/Heart-Failur...
#CardioSky #MedSky #Cardiology
0
0
1
0
6/11
#HeartFailure2025 Late-Breaking Science!
CPETs are increasingly becoming embedded in P2/3 trials of HF and cardiomyopathy. New data support complementary information alongside traditional biomarkers and outcome capture.
#CardioSky #MedSky #Cardiology
0
0
1
0
5/11
Intriguing new data out in @jaccjournals.bsky.social in time for #HeartFailure2025 from ATTRibuteCM.
Stabilization of TTR (prealbumin) leads to immediate & sustained rise in TTR levels.
Degree of rise identifies those likely to derive mortality protection from TTR stabilizers
#CardioSky
0
0
1
0
4/11
Simultaneous Publication with #HeartFailure2025 in
@ahajournals.bsky.social
www.ahajournals.org/doi/abs/10.1...
Late-Life Echocardiographic Effects of the Amyloidogenic p.V142I Transthyretin Variant. Suggests large subclinical risk & close monitoring for disease progression among carriers
0
0
1
0
3/11
Remarkable back-to-back! #HeartFailure2025 #LBCT by
Marianna Fontana.
Nex-z CRISPR gene editing based therapy in #ATTRCM. Main paper in @nejm.org www.nejm.org/doi/full/10....
New data by #ATTR type with consistent and durable TTR lowering
#CardioSky #MedSky #Cardiology
0
0
1
0
2/11
#HeartFailure2025 Simultaneous Publication in
@jaccjournals.bsky.social
Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy: HELIOS-B
www.jacc.org/doi/10.1016/...
#CardioSky #MedSky #Cardiology
1
1
1
0
1/11
Muthu Vaduganathan helped us share insights from #HeartFailure2025. Here are some highlights:
#LBCT by Marianna Fontana
#HELIOSB Recently FDA approved Vutrisiran RNAi therapeutic reduces mortality through 42 months in #ATTRCM
#CardioSky #MedSky #Cardiology
0
0
1
0
At #HeartFailure2025, DCRI experts presented at 11 different sessions, including three late-breaking science sessions. Learn more about the new research shared during these sessions, which featured Stephen Greene, Mark Kittipibul, and Marat Fudim as presenters. dcri.org/news/esc-hea...
#CardioSky
1
2
0
0
Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence.
#HFA_ESC #HeartFailure2025
3
4
1
0
French study: Two out of five patients with heart failure do not see a cardiologist even once a year and these patients are more likely to die ow.ly/3jPf50VUqEm
#HeartFailure2025 #HFA_ESC
1
2
1
0
AI-enabled #ECG algorithm performs well in the early detection of #heartfailure in Kenya
Read more: ow.ly/CKTq50VUp4o
#HeartFailure2025 #HFA_ESC
3
3
1
0
Happy and proud to have two oral communications selected as Highlights at #HeartFailure2025
Chloride subanalysis of the ALCALOTIC study with simpub in IEM online link.springer.com/article/10.100…
HypoK+ in the CLOROTIC trial will be published soon (hopefully)
0
0
0
0
An analysis of the Phase 3 HELIOS-B study of vutrisiran (AMVUTTRA) for ATTR-CM supported the trial’s primary findings, with a reduction of mortality and key cardiovascular events.
🔗 www.hcplive.com/view...
#Cardiology #HeartFailure2025
0
0
0
0
LBCT insights from SEQUOIA-HCM at #HeartFailure2025: #aficamten as effective in mildly symptomatic pts w/ #oHCM (NYHA class II/KCCQ-CSS ≥80) as in pts w/ moderate to severe sx. Now published in EHJ! doi.org/10.1093/eurheartj/ehaf364 #CardioSky #MedSky
1
0
0
0
If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist, according to study published by @escardio.bsky.social & presented at #HeartFailure2025 tiny.cc/n76k001
0
1
2
0
Day 2️⃣ of #HeartFailure2025 has started! 🏁
Ready to learn how to #decongest your decompensated #heartfailure patient?🫀💦
@novitham.bsky.social @escardio.bsky.social
9
3
0
0
It’s a busy conference weekend! Today is the start of:
• #HeartFailure2025 in Belgrade
• #SCT2025 in Vancouver
• #ATS2025 in San Francisco
Check the images below for the rundown on DCRI member sessions.
1
0
0
0
Semra Ozdemir and Juan Marcos Gonzalez will be wrapping up the DCRI’s PrefER & Duke Department of Population Health Sciences’ presence at #ISPORAnnual. Check back for updates on the conferences starting this weekend, including #HeartFailure2025, #SCT2025, and #ATS2025.
0
0
0
0
Starting tomorrow ➡️ #HeartFailure2025 🎉🎉
What I am most looking forward to:
⭐️ Topnotch #LBCT sessions
⭐️ #HFAYoung track - not to miss sessions ‼️
⭐️ #HFA_ESC millionaire quiz - daily at the HFA stage 🏆
⭐️ Meeting old & new friends ✨
Will I see you there? 🙋♀️
@novitham.bsky.social @escardio.bsky.social
6
4
2
0
#Heartfailure2025 is coming
📍Belgrade 🇷🇸
📅 17-20 May
We are pleased to present 4 abstracts from our latest sub-analysis of the #CLOROTIC trial and #ALCALOTIC study
Thanks again to all the investigators, collaborators, and presenters
#Teamwork
1
0
1
0
Towards a sustainable future – together!
Are you attending #HeartFailure2025 ? Let’s make your stay eco-friendly with simple yet impactful choices.
Discover our tips for a more sustainable stay: ow.ly/AorQ50VQO56
#HFA_ESC #Sustainability
6
3
1
0
From 17 to 20 May, the global heart failure community will unite at #HeartFailure2025, in Belgrade & online 🌍.
@escardio.bsky.social
4
4
1
0
From 17 to 20 May, the global heart failure community will unite at #HeartFailure2025, in Belgrade & online 🌍
Get 80+ sessions across the spectrum of HF, Late-Breaking Science, how-to learning & up to 22.5 CME Credits.
Join onsite or online & experience the science! bit.ly/4iEZ9A5
#HFA_ESC
2
2
1
0
The experts will be at #HeartFailure2025. Will you?
How-to sessions, interactive discussions, 10 Late-Breaking Science sessions, opportunities to collaborate… and that’s just the start.
Register by 17 April to save 👇
ow.ly/psq450VCwbt
2
2
1
0
📣 Applications for HFA Career Café 2025 are NOW OPEN 🎉
➡️exclusive chance to connect one-on-one with top cardiology experts at #HeartFailure2025 🩺✨
💥 Limited spots available – Be the first to register!
🔗 Apply now: bit.ly/41SyPfo
@novitham.bsky.social @escardio.bsky.social
2
1
0
0
Join international experts at #HeartFailure2025! 🌍
Discover cutting-edge science and gain fresh insights to elevate your practice.
Register by March 17 to save the most 👉
bit.ly/4hR37FO
#CardiologyResearch #HeartFailureResearch
3
2
0
0
⚠️ Deadline Reminder:
Abstract Submission for #HeartFailure2025 is closing soon!
📚Abstracts – 14 January, 12:00 CET
📚Clinical Cases – 21 January, 12:00 CET
⏳ Don’t wait, submit now & be part of this exciting event!🙌🏻
➡️ www.escardio.org/Congresses-E...
#CardioSky #HFA_ESC
@escardio.bsky.social
3
5
1
0